Neurobiology of adolescent substance use disorders: implications for prevention and treatment
- PMID: 20682216
- PMCID: PMC2928062
- DOI: 10.1016/j.chc.2010.03.003
Neurobiology of adolescent substance use disorders: implications for prevention and treatment
Abstract
Adolescence represents a unique period of development with neuronal maturation accompanied by increases in behavioral risk taking. Although risky behavior is a likely marker of normative adolescent development, there is an early emergence of substance use disorders in this population. Adolescence represents a distinct period of vulnerability to substance use initiation and transitions to substance abuse and dependence. Of recent interest is understanding the neurobiology of adolescent substance use disorders, with adult studies being limited in their applicability to this developmentally sensitive maturation period and providing restricted insight into potential treatment and intervention. First, the authors review the neurobiology of adolescent substance use disorders and, second, the authors consider the implications of these findings for prevention and treatment.
Copyright (c) 2010 Elsevier Inc. All rights reserved.
References
-
- Wagner FA, Anthony JC. From first drug use to drug dependence - developmental periods of risk for dependence upon marijuana, cocaine, and alcohol. Neuropsychopharmacology. 2002;26(4):479–88. - PubMed
-
- Kelley AE, Schochet T, Landry CF. Risk taking and novelty seeking in adolescence: Introduction to part I. Ann N Y Acad Sci. 2004;1021(1):27–32. - PubMed
-
- Friedman AS, Terras A, Zhu W. Early adolescent substance use/abuse as predictor to employment in adulthood: Gender differences. Journal of Child & Adolescent Substance Abuse. 2004;13(4):49–60.
-
- McGue M, lacono WG. The association of early adolescent problem behavior with adult psychopathology. Am J Psychiatry. 2005;162(6):1118–24. - PubMed
Publication types
MeSH terms
Grants and funding
- UL1 RR024139/RR/NCRR NIH HHS/United States
- RL1 AA017539/AA/NIAAA NIH HHS/United States
- R01 DA006025/DA/NIDA NIH HHS/United States
- R01 DA017863/DA/NIDA NIH HHS/United States
- P50 DA016556/DA/NIDA NIH HHS/United States
- R01 DA019039/DA/NIDA NIH HHS/United States
- P50 DA09241/DA/NIDA NIH HHS/United States
- R01 DA018647/DA/NIDA NIH HHS/United States
- R21 DA024232/DA/NIDA NIH HHS/United States
- P01 DA022446/DA/NIDA NIH HHS/United States
- P50 DA009241/DA/NIDA NIH HHS/United States
- R01 DA06025/DA/NIDA NIH HHS/United States
- UL1 DE019586/DE/NIDCR NIH HHS/United States
- R01 DA020908/DA/NIDA NIH HHS/United States
- R01 HD044796/HD/NICHD NIH HHS/United States